10.09.2014 22:48:37

Baxter Reveals Name Of New Global Biopharmaceutical Company

(RTTNews) - Baxter International Inc. (BAX) said Wednesday that Baxalta Inc. will be the name of the new, publicly traded biopharmaceutical company that is expected to launch in mid-2015.

Upon completion of the separation, Baxalta plans to trade on the New York Stock Exchange under the symbol BXLT. Baxter International will continue trading on the NYSE under the symbol BAX.

The corporate headquarters of both companies will be located in northern Illinois.

In March, Baxter announced its plan to separate into two healthcare companies - one focused on developing biopharmaceuticals and the other on medical products.

Analysen zu Baxter International Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Baxter International Inc. 30,06 -0,66% Baxter International Inc.